Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2026Advances in TherapyOpen Access

Major 2025 cardiology trials highlight broad clinical advances and the safety of shortened DAPT.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

With rapid advancements in cardiovascular disease management, it is critical to evaluate emerging clinical trial evidence that may influence clinical practice and future guidelines.

Population

Over 80 key cardiology clinical trials published or presented in 2025

Design

Review

Key result

Major cardiology clinical trials from 2025 demonstrated significant advances across coronary, structural, heart failure, and preventive cardiology, including the safety of shortened dual antiplatelet therapy strategies.

Authors

MTMatthew ToddPSP SavageMCM. Campbell

Discussion

Loading...

Member takes

Overview

Summarizes 2025 cardiology trials; leaves open which results warrant practice changes pending guideline review.

Key Points

  • This review aims to synthesize key clinical trials in cardiology from 2025, assessing their impact on clinical practice.
  • Evaluated trials presented at major cardiology conferences in 2025.
  • Focused on trials likely to change current clinical practices.
  • Included trials from organizations such as ACC, ESC, AHA, and others.
  • Identified over 80 key clinical trials in cardiology for 2025.
  • Notable advancements in percutaneous coronary intervention and dual antiplatelet therapy were highlighted, challenging traditional paradigms.
  • Major findings in structural heart disease therapies and heart failure treatments were reported.

Structured PICO

P
Population
A review of over 80 major cardiology clinical trials published or presented in 2025 evaluating emerging cardiovascular therapies and interventions.

This comprehensive review synthesizes key 2025 cardiology trials, highlighting critical advances in shortened DAPT strategies, novel PCI technologies, and complex revascularization that are likely to influence future clinical guidelines.

Limitations

  • The review relies on previously conducted studies and includes selected early-phase or mechanistic studies where findings were considered hypothesis-generating.

Cite This Study

Todd et al. (2026) conducted a review in Cardiovascular diseases. Cardiovascular therapies and interventions was evaluated. Major cardiology clinical trials from 2025 demonstrated significant advances across coronary, structural, heart failure, and preventive cardiology, including the safety of shortened dual antiplatelet therapy strategies.

synapsesocial.com/papers/6a2e4855b1cc60ccdea8ca3fhttps://doi.org/10.1007/s12325-026-03653-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advances in Clinical Cardiology 2024: A Summary of Key Clinical Trials2025 · 5 citations
  2. 2Advances in Clinical Cardiology 2022: A Summary of Key Clinical Trials2023 · 5 citations
  3. 3Advances in Clinical Cardiology 2021: A Summary of Key Clinical Trials2022 · 18 citations
  4. 4Advances in Clinical Cardiology 2019: A Summary of Key Clinical Trials2020 · 12 citations
  5. 5Advances in Clinical Cardiology 2017: A Summary of Key Clinical Trials2018 · 3 citations